Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): study protocol for a phase iii randomized controlled trial

BACKGROUND: Approximately 20 % of hepatocellular carcinoma (HCC) patients diagnosed in the early stages may benefit from potentially curative ablative therapies such as surgical resection, transplantation or radiofrequency ablation. For patients not eligible for such options, prognosis is poor. Sora...

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Mihir, Choo, Su Pin, Thng, Choon Hua, Tan, Say Beng, Low, Albert Su Chong, Cheow, Peng Chung, Goh, Anthony Soon Whatt, Tay, Kiang Hiong, Lo, Richard Hoau Gong, Goh, Brian Kim Poh, Wong, Jen San, Ng, David Chee Eng, Soo, Khee Chee, Liew, Wei Ming, Chow, Pierce K. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100089/
https://www.ncbi.nlm.nih.gov/pubmed/27821083
http://dx.doi.org/10.1186/s12885-016-2868-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100089/
https://www.ncbi.nlm.nih.gov/pubmed/27821083
http://dx.doi.org/10.1186/s12885-016-2868-y

Ejemplares similares